Applying for official documents in the Philippines used to mean long lines and hours of waiting. Fortunately, technology has changed the game for many government services. The process for securing a ...

CAMBRIDGE, Mass., Sept. 9, 2025 /PRNewswire/ -- ARTBIO, Inc. ("ARTBIO"), a clinical-stage radiopharmaceutical company developing a new class of Pb212 alpha radioligand therapies (ARTs), today ...

CAMBRIDGE, Mass., Aug. 7, 2025 /PRNewswire/ -- K36 Therapeutics, Inc. ("K36"), a privately held clinical-stage biotechnology company developing novel, targeted therapies for cancers with unmet medical ...

NATIONAL Bureau of Investigation (NBI) Director Jaime Santiago has ordered an internal investigation into a controversial July operation conducted by the agency’s Special Task Force (STF) in Malolos ...

NEW TAIPEI CITY, July 28, 2025 /PRNewswire/ -- Caliway Biopharmaceuticals (TWSE: 6919) today announced that the U.S. Food and Drug Administration (FDA) has granted clearance to proceed with SUPREME-01 ...

MRT-8102, a highly selective NEK7-directed molecular glue degrader (MGD) developed to treat inflammatory conditions linked to NLRP3, IL-1β, and IL-6 dysregulation, expands Monte Rosa’s clinical I&I ...

SHANGHAI, June 5, 2025 /PRNewswire/ -- YolTech Therapeutics, a clinical-stage biotechnology company developing in vivo genome editing therapies, today announced that the U.S. Food and Drug ...

(RTTNews) - Erasca, Inc. (ERAS) announced clearance of an investigational new drug application by the FDA for ERAS-4001, a potential first-in-class and best-in-class pan-KRAS inhibitor, for the ...

SHANGHAI and SAN DIEGO, May 22, 2025 /PRNewswire/ -- Duality Biotherapeutics ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing ...